- Report
- July 2024
- 208 Pages
Global
From €5495EUR$6,000USD£4,678GBP
- Report
- July 2024
- 120 Pages
Global
From €4350EUR$4,750USD£3,704GBP
- Report
- July 2024
- 170 Pages
Global
From €4350EUR$4,750USD£3,704GBP
- Report
- March 2025
- 183 Pages
Global
From €4121EUR$4,500USD£3,509GBP
- Report
- March 2025
- 183 Pages
Global
From €4121EUR$4,500USD£3,509GBP
- Report
- March 2025
- 81 Pages
Global
From €9154EUR$9,995USD£7,793GBP
- Report
- January 2025
- 127 Pages
Global
From €2702EUR$2,950USD£2,300GBP
- Report
- May 2024
- 119 Pages
Global
From €1786EUR$1,950USD£1,520GBP
- Report
- December 2024
- 150 Pages
Global
From €3075EUR$3,358USD£2,618GBP
€3617EUR$3,950USD£3,080GBP
- Report
- December 2024
- 150 Pages
Global
From €3075EUR$3,358USD£2,618GBP
€3617EUR$3,950USD£3,080GBP
- Report
- January 2025
- 119 Pages
Global
From €3500EUR$4,094USD£3,084GBP
- Report
- December 2024
- 150 Pages
Global
From €3075EUR$3,358USD£2,618GBP
€3617EUR$3,950USD£3,080GBP
- Report
- March 2025
- 74 Pages
Global
From €9154EUR$9,995USD£7,793GBP
- Report
- April 2025
Global
From €3617EUR$3,950USD£3,080GBP
- Report
- May 2025
- 179 Pages
Global
From €5358EUR$5,850USD£4,561GBP
- Report
- March 2025
- 130 Pages
Global
From €3998EUR$4,365USD£3,403GBP
€4442EUR$4,850USD£3,782GBP
- Report
- February 2025
- 130 Pages
Global
From €3998EUR$4,365USD£3,403GBP
€4442EUR$4,850USD£3,782GBP
- Report
- February 2025
- 225 Pages
Global
From €4121EUR$4,500USD£3,509GBP
- Report
- January 2025
- 196 Pages
Global
From €4575EUR$4,995USD£3,895GBP
- Report
- January 2025
- 191 Pages
Global
From €4575EUR$4,995USD£3,895GBP

The Antibodies market is a subset of the Immune Disorders Drugs market, which focuses on treatments for conditions related to the immune system. Antibodies are proteins produced by the body to fight off foreign substances, such as bacteria and viruses. They are used to treat a variety of immune-related conditions, including autoimmune diseases, allergies, and cancer. Antibodies can be used in combination with other drugs, such as steroids, to reduce inflammation and improve symptoms. They can also be used to target specific cells or proteins in the body, allowing for more targeted treatments.
The Antibodies market is highly competitive, with a number of companies offering a variety of products. Companies such as AbbVie, Amgen, and Biogen are leading the way in developing and marketing antibodies for the treatment of immune-related conditions. Other companies, such as Genentech and Regeneron, are also active in the market, offering a range of products for different conditions. Show Less Read more